Small bowel magnetic resonance imaging for inflammatory bowel disease

Topics in Magnetic Resonance Imaging

Volumn 13, Issue 6, 2002, Pages 409-425

  Schunk, Klaus ^a,b  

^a Dept Anesth   (Germany)

^b Chefarzt der Radiologie Klinikum   (Germany)

Author keywords

Hydromagnetic resonance imaging; Inflammatory activity; Inflammatory bowel disease; Mannitol solution; Oral bowel opacification

Indexed keywords

BARIUM SULFATE; CONTRAST MEDIUM; ENDOFALK; FERRIC AMMONIUM CITRATE; FORMIC ACID; GADOLINIUM PENTETATE; ISPAGULA; MACROGOL; MACROGOL 3350; MANGANESE CHLORIDE; MANNITOL; METHYLCELLULOSE; PERFLUOROOCTYL BROMIDE; SCOPOLAMINE BUTYL BROMIDE;

ARTICLE; CROHN DISEASE; DIAGNOSTIC VALUE; DIARRHEA; DISEASE ACTIVITY; ENTERITIS; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE STENOSIS; METEORISM; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; SMALL INTESTINE DISEASE; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; CONTRAST MEDIA; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINE, SMALL; MAGNETIC RESONANCE IMAGING;

EID: 0036913515     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002142-200212000-00005     Document Type: Article

References (71)

1. Bernstein CN, Boult IF, Greenberg HM, et al. A prospective randomized comparison between small bowel enteroclysis and small bowel follow-through in Crohn's disease. Gastroenterology 1997;113:390-398.
2. Maglinte DD, Chernish SM, Kelvin FM, et al. Crohn disease of the small intestine: Accuracy and relevance of enteroclysis. Radiology 1992;184:541-545.
3. Thoeni RF, Gould RG. Enteroclysis and small bowel series: Comparison of radiation dose and examination time. Radiology 1991;178:659-662.
4. Kettritz U, Isaacs K, Warshauer DM, et al. Crohn's disease. Pilot study comparing MRI of the abdomen with clinical evaluation. J Clin Gastroenterol 1995;21:249-253.
5. Schunk K, Metzmann U, Kersjes W, et al. Verlaufskontrolle des Morbus Crohn: Kann die hydro-MRT die fraktionierte magendarm-passage ersetzen? Fortschr Röntgenstr 1997;166:389-396.
6. Halligan S, Saunders B, Williams C, et al. Adult Crohn disease: Can ileoscopy replace small bowel radiology? Abdom Imaging 1998;23:117-121.
7. Fürst H, Schildberg FW. Chirurgische behandlung entzündlicher darmerkrankungen. Radiologe 1998;38:8-14.
8. Schober E, Turetschek K, Mostbeck G. Die radiologische abklärung des Morbus Crohn. Radiologe 1998;38:15-22.
9. Acciuffi S, Ghosh S, Ferguson A. Strengths and limitations of the Crohn's disease activity index, revealed by an objective gut lavage test of gastrointestinal protein loss. Aliment Pharmacol Ther 1996;10:321-326.
10. Goebell H, Wienbeck M, Schomerus H, et al. Evaluation of the Crohn's Disease Activity Index (CDAI) and the Dutch Index for severity and activity of Crohn's disease. An analysis of the data from the European Cooperative Crohn's Disease Study. Med Klin 1990;85:573-576.
11. Andre C, Descos L, Landais P, et al. Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index. Gut 1981;22:571-574.
12. Andre C, Descos L, Vignal J, et al. C-reactive protein as a predictor of relapse in asymptomatic patients with Crohn's disease. Scott Med J 1983;28:26-29.
13. Bigard M, Gaucher P, Lasalle C. Fatal colonic explosion during colonoscopic polypectomy. Gastroenterology 1979;77:1307-1310.
14. Regan F, Beall D, Bohlmann M, et al. Fast MR imaging and the detection of small-bowel obstruction. AJR Am J Roentgenol 1998;170:1465-1469.
15. Shoenut JP, Semelka RC, Magro CM, et al. Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease. J Clin Gastroenterol 1994;19:31-35.
16. Anderson CM, Brown JJ, Balfe DM, et al. MR imaging of Crohn disease: Use of perflubron as a gastrointestinal contrast agent. J Magn Reson Imaging 1994;4:491-496.
17. Rijcken THP, Davis MA, Ros PR. Intraluminal contrast agents for MR imaging of the abdomen and pelvis. J Magn Reson Imaging 1994;4:291-300.
18. Ernst O, Asselah T, Cablan X, et al. Breath-hold fast spin-echo MR imaging of Crohn's disease. AJR Am J Roentgenol 1998;170:127-128.
19. Holzknecht N, Helmberger T, von Ritter C, et al. Dünndarm-MRT mit schnellen MR-sequenzen bei Morbus Crohn nach enteroklysma mit oralen eisenpartikeln. Radiologe 1998;38:29-36.
20. Rieber A, Wruk D, Nüssle K, et al. MRT des abdomens in kombination mit der enteroklyse bei Morbus Crohn unter verwendung von oralem und intravenösem Gd-DTPA. Radiologe 1998;38:23-28.
21. Aschoff AJ, Zeitler H, Merkle EM, et al. MR-enteroklyse zur kernspintomographischen diagnostik entzundlicher darmerkrankungen mit verbesserter darmkontrastierung. Fortschr Röntgenstr 1997;167:387-391.
22. Hansmann HJ, Kosa R, Dfix M, et al. Hydro-MRT chronisch entzündlicher darmerkrankungen. Fortschr Röntgenstr 1997;167:132-138.
23. Laghi A, Carbone I, Catalano C, et al. Polyethylene glycol solution as an oral contrast agent for MR imaging of the small bowel. AJR Am J Roentgenol 2001;177:1333-1334.
24. Krahe T, Dölken W, Lackner K, et al. Gadolinium-DTPA als orales kontrastmittel für die MR-tomographie des abdomens. Fortschr Röntgenstr 1990;153:17-73.
25. Bernardino ME, Weinreb JC, Mitchell DG, et al. Safety and optimum concentration of a manganese chloride-based oral MR contrast agent. J Magn Reson Imaging 1994;4:872-876.
26. Hirohashi S, Hirohashi R, Uchida H, et al. [MR imaging oral contrast agent mixed with milk for the small intestine]. Nippon Igaku Hoshasen Gakkai Zasshi 1994;54:784-788.
27. Hirohashi S, Uchida H, Yoshikawa K, et al. Large scale clinical evaluation of bowel contrast agent containing ferric ammonium citrate in MRI. Magn Reson Imaging 1994;12:837-846.
28. Patak MA, Froehlich JM, von Weymarn C, et al. Non-invasive distension of the small bowel for magnetic-resonance imaging. Lancet 2001;358:987-988.
29. Schunk K, Kersjes W, Schadmand-Fischer S, et al. Aqueous mannitol solution as oral bowel contrast agent for pelvic MRI. Advanced Magnetic Resonance AMR'95: Book of Abstracts 1995;85:85.
30. Tart RP, Li KC, Storm BL, et al. Enteric MRI contrast agents: Comparative study of five potential agents in humans. Magn Reson Imaging 1991;9:559-568.
31. Umschaden HW, Szolar D, Gasser J, et al. Small-bowel disease: Comparison of MR enteroclysis images with conventional enteroclysis and surgical findings. Radiology 2000;215:717-725.
32. Schunk K, Wießner J, Schadmand S, et al. Zur frage der darmkon trastierung in der abdominellen computertomographie. Fortschr Röntgenstr 1992;156:443-447.
33. Schunk K, Kersjes W, Schadmand-Fischer S, et al. Eine mannitollösung als orales kontrastmittel in der pelvinen MRT. Fortschr Röntgenstr 1995;163:60-66.
34. Schunk K, Kersjes W, Schadmand-Fischer S, et al. Optimierung pelviner MR-diagnostik durch ein neues gastro-intestinales kontrastmittel. Akt Radiol 1995;5:259-262.
35. Schunk K, Kern A, HeuBel CP, et al. Hydro-MRT mit schnellen sequenzen bei M. Crohn: Vergleich mit der fraktionierten MagenDarm-passage. Fortschr Röntgenstr 1999;170:338-346.
36. Schunk K, Kern A, Heußel CP, et al. Hydro-MRT bei M. Crohn: Ist eine beurteilung der klinischen aktivität möglich? Fortschr Röntgenstr 2000;172:153-160.
37. Schunk K, Kern A, Oberholzer K, et al. Hydro-MRI in Crohn's disease: Appraisal of disease activity. Invest Radiol 2000;35:431-437.
38. Schunk K, Reiter S, Vogel N, et al. Activity assessment in ulcerative colitis: A comparison between hydro-MRI and endoscopy. Eur Radiol 2001;11:S140.
39. Schunk K, Reiter S, Oberholzer K, et al. Activity assessment in Crohn's disease: A comparison between hydro-MRI and endoscopy. Eur Radiol 2001;11:S274.
40. Schunk K, Adamek HE: Möglichkeiten und grenzen der kernspintomographie in der diagnostik von biliopankreatischen und darmerkrankungen. Der Internist 2001;4:507-515.
41. Schunk K, Reiter S, Kern A, et al. Hydro-MRT bei entzündlichen darmerkrankungen-eine koloskopisch-histologische vergleichsstudie. Fortschr Röntgenstr 2001;173:731-738.
42. Schunk K, Düber C, Kreitner K, et al. Darmkontrastierung bei der abdominellen computertomographie: Wasser oder kontrastmittel? Fortschr Röntgenstr 1991;154:5-11.
43. Lee JKT, Marcos H, Semelka R: MR imaging of the small bowel using the HASTE sequence. AJR Am J Roentgenol 1998;170:1457-1463.
44. Shoenut JP, Semelka RC, Silverman R, et al. Magnetic resonance imaging in inflammatory bowel disease. J Clin Gastroenterol 1993;17:73-78.
45. Jabra AA, Fishman EK, Taylor GA: Crohn disease in the pediatric patient: CT evaluation. Radiology 1991;179:495-498.
46. Klein HM, Wein B, Adam G, et al. Computertomographische morphologie von Morbus Crohn und Colitis ulcerosa. Fortschr Röntgenstr 1995;163:9-15.
47. Koh DM, Miao Y, Chinn RJ, et al. MR imaging evaluation of the activity of Crohn's disease. AJR Am J Roentgenol 2001;177:1325-1332.
48. D'Arienzo A, Scaglione G, Vicinanza G, et al. Magnetic resonance imaging with ferumoxil, a negative superparamagnetic oral contrast agent, in the evaluation of ulcerative colitis. Am J Gastroenterol 2000;95:720-724.
49. Madsen S, Thomsen H, Schlichting P, et al. Evaluation of treatment response in active Crohn's disease by low field magnetic resonance imaging. Abdom Imaging 1999;24:232-239.
50. Maccioni F, Viscido A, Broglia L, et al. Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 2000;25:219-228.
51. Funt SA, Krinsky G, Horowitz L. Clinical image. MR demonstration of submucosal fat in a patient with Crohn's disease. J Comput Assist Tomogr 1996;20:940-941.
52. Rha SE, Ha HK, Lee SH, et al. CT and MR imaging findings of bowel ischemia from various primary causes. Radiographics 2000;20:29-42.
53. Meyers MA, McGuire PV. Spiral CT demonstration of hypervascularity in Crohn disease: "Vascular jejunization of the ileum" or the "comb sign." Abdom Imaging 1995;20:327-332.
54. Prassopoulos P, Papanikolaou N, Grammatikakis J, et al. Spectrum of Crohn's disease abnormalities demonstrated by MR enteroclysis: Initial results. Eur Radiol 2002;12(suppl 1):313.
55. Kleinhaus U, Welch Y. Computed tomography of Crohn's disease Reevaluation. Fortschr Röntgenstr 1987;147:607-611.
56. Philpotts LE, Heiken JP, Westcott MA, et al. Colitis: Use of CT findings in differential diagnosis. Radiology 1994;190:445-449.
57. Skalej M, Makowiec F, Weinlich M, et al. Kernspintomographie bei perianalem Morbus Crohn. Dtsch Med Wochenschr 1993;118:1791-1796.
58. Haggett PJ, Moore NR, Shearman JD, et al. Pelvic and perineal complications of Crohn's disease: Assessment using magnetic resonance imaging. Gut 1995;36:407-410.
59. Koelbel G, Schmiedl U, Majer MC, et al. Diagnosis of fistulae and sinus tracts in patients with Crohn disease: Value of MR imaging. AJR Am J Roentgenol 1989;152:999-1003.
60. Rieber A, Aschoff A, Nussle K, et al. MRI in the diagnosis of small bowel disease: Use of positive and negative oral contrast media in combination with enteroclysis. Eur Radiol 2000;10:1377-1382.
61. Meryn S, Lochs H, Bettelheim P, et al. Serumproteinkonzentrationen-parameter für die krankheitsaktivität bei Morbus Crohn? Leber Magen Darm 1985;15:160-164.
62. Lopez-Morante AJ, Saez-Royuela F, Yuguero del Moral L, et al. The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease. Rev Esp Enferm Dig 1993;83:5-9.
63. Hansmann HJ, Hess T, Hahmann H, et al. MRT chronisch entzündlicher darmerkrankungen. Fortschr Röntgenstr 2001;173:4-11.
64. Paley MR, Ros PR. MRI of the gastrointestinal tract. Eur Radiol 1997;7:1387-1397.
65. Dumo C, Sherman P, Williams T, et al. Magnetic resonance imaging to distinguish the type and severity of pediatric inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 2000;30:170-174.
66. Sardanelli F, de Cicco E, Renzetti P, et al. Double-contrast magnetic resonance examination of ulcerative colitis. Eur Radiol 1999;9:875-879.
67. Ha HK, Lee EH, Lim CH, et al. Application of MRI for small intestinal diseases. J Magn Reson Imaging 1998;8:375-383.
68. Akhan O, Pringot J. Imaging of abdominal tuberculosis. Eur Radiol 2002;12:312-323.
69. Boudiaf M, Zidi S, Soyer P, et al. Tuberculous colitis mimicking Crohn's disease: Utility of computed tomography in the differentiation. Eur Radiol 1998;8:1221-1223.
70. Fujiyoshi F, Ichinari N, Kajiya Y, et al. Retractile mesenteritis: Small-bowel radiography, CT, and MR imaging. AJR Am J Roentgenol 1997;169:791-793.
71. Katayama M, Masui T, Kobayashi S, et al. Evaluation of pelvic adhesions using multiphase and multislice MR imaging with kinematic display. AJR Am J Roentgenol 2001;177:107-110.